Drug
Irinotecan (drug)
Irinotecan (drug) is a pharmaceutical drug with 5 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
3
60%
Ph phase_2
2
40%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Completed(1)
Detailed Status
Recruiting3
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (60.0%)
Phase 22 (40.0%)
Trials by Status
not_yet_recruiting120%
recruiting360%
completed120%
Recent Activity
3 active trials
Showing 5 of 5
recruitingphase_1
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
NCT06208657
not_yet_recruitingphase_1
To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer
NCT07364422
recruitingphase_1
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
NCT07334301
recruitingphase_2
Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer
NCT07150247
completedphase_2
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
NCT00318903
Clinical Trials (5)
Showing 5 of 5 trials
NCT06208657Phase 1
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
NCT07364422Phase 1
To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer
NCT07334301Phase 1
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
NCT07150247Phase 2
Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer
NCT00318903Phase 2
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5